LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $309,786 | -18.5% | 5,170 | -1.9% | 0.07% | -50.7% |
| Q2 2023 | $379,895 | -39.5% | 5,269 | -38.3% | 0.14% | -57.9% |
| Q1 2023 | $627,835 | +95.9% | 8,535 | +77.9% | 0.34% | +113.8% |
| Q4 2022 | $320,440 | -64.4% | 4,797 | -54.1% | 0.16% | -49.5% |
| Q3 2022 | $900,000 | -3.4% | 10,450 | 0.0% | 0.32% | -22.1% |
| Q2 2022 | $932,000 | -20.7% | 10,450 | 0.0% | 0.41% | -26.0% |
| Q1 2022 | $1,176,000 | -27.3% | 10,450 | -0.2% | 0.55% | +103.0% |
| Q4 2021 | $1,618,000 | -0.7% | 10,473 | -10.5% | 0.27% | +105.3% |
| Q3 2021 | $1,630,000 | -9.2% | 11,700 | -14.5% | 0.13% | -41.6% |
| Q2 2021 | $1,796,000 | -27.9% | 13,689 | -16.2% | 0.23% | -45.7% |
| Q1 2021 | $2,490,000 | -68.1% | 16,332 | -79.2% | 0.42% | -47.2% |
| Q4 2020 | $7,805,000 | +97.4% | 78,478 | +89.2% | 0.79% | +109.0% |
| Q3 2020 | $3,954,000 | +64.2% | 41,485 | +92.7% | 0.38% | +140.1% |
| Q2 2020 | $2,408,000 | – | 21,531 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |